5155262: SULFAMETHOXAZOLE AND TRIMETHOPRI.
SULFAMETHOXAZOLE AND TRIMETHOPRI. Key specifications include administration: ORAL, primary_container_type: BOTTLE, PLASTIC, medical_designation_and_grade: UNITED STATES PHARMACOPEIA, total_primary_container_quantity: 500, primary_container_content_quantity: 500.0 TABLETS, active_medicament_medicinal_strength: 800.0 MILLIGRAMS SULFAMETHOXAZOLE ACTIVE INGREDIENT AND 160.0 MILLIGRAMS TRIMETHOPRIM ACTIVE INGREDIENT. This part is cataloged in the U.S.
Government catalog under NSN 6505-01-723-9101, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.
Verify compatibility with your specific system configuration before ordering.
| administration | ORAL |
| primary_container_type | BOTTLE, PLASTIC |
| medical_designation_and_grade | UNITED STATES PHARMACOPEIA |
| total_primary_container_quantity | 500 |
| primary_container_content_quantity | 500.0 TABLETS |
| active_medicament_medicinal_strength | 800.0 MILLIGRAMS SULFAMETHOXAZOLE ACTIVE INGREDIENT AND 160.0 MILLIGRAMS TRIMETHOPRIM ACTIVE INGREDIENT |
| part_name_assigned_by_controlling_agency | SULFAMETHOXAZOLE AND TRIMETHOPRIM TABLETS USP BOTTLE 500S |
| NSN | 6505-01-723-9101 |
| ADMINISTRATION | ORAL |
| PRIMARY CONTAINER CONTENT QUANTITY | 500.0 TABLETS |
| MEDICAL DESIGNATION AND GRADE | UNITED STATES PHARMACOPEIA |
| PRIMARY CONTAINER TYPE | BOTTLE, PLASTIC |
| SPECIAL FEATURES | SULFAMETHOXAZOLE AND TRIMETHOPRIM TABLETS, 800 MG SULFAMETHOXAZOLE, USP AND 160 MG TRIMETHOPRIM, FOR ORAL ADMINISTRATION; STORE AT 20 TO 25 C (68 TO 77 F) (SEE USP CONTROLLED ROOM TEMPERATURE); BOTTLE OF 500 TABLETS. |
| PART NAME ASSIGNED BY CONTROLLING AGENCY | SULFAMETHOXAZOLE AND TRIMETHOPRIM TABLETS USP BOTTLE 500S |
| ACTIVE MEDICAMENT MEDICINAL STRENGTH | 800.0 MILLIGRAMS SULFAMETHOXAZOLE ACTIVE INGREDIENT AND 160.0 MILLIGRAMS TRIMETHOPRIM ACTIVE INGREDIENT |
| TOTAL PRIMARY CONTAINER QUANTITY | 500 |